Rang	Name	Position
1	Mr. Samuel N. Hazen	CEO & Director
2	Mr. Michael A. Marks	CFO & Executive VP
3	Mr. Jon Mack Foster	Executive VP & COO
4	Mr. Michael R. McAlevey	Executive VP and Chief Legal & Administrative Officer
5	Dr. Michael S. Cuffe M.B.A., M.D.	Executive VP & Chief Clinical Officer
6	Dr. Thomas F. Frist Jr., M.D.	Founder & Chairman Emeritus
7	Mr. Christopher F. Wyatt	Senior VP, Principal Accounting Officer & Controller
8	Mr. Chad J. Wasserman	Senior VP & Chief Information Officer
9	Mr. Frank George Morgan C.F.A.	Vice President of Investor Relations
10	Ms. Wendy Warren	Senior VP and Chief Ethics & Compliance Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Vanguard Group Inc	6,63%	6,01 Mrd. USD
2	BlackRock Inc	6,02%	5,46 Mrd. USD
3	Vanguard Capital Management, LLC	4,59%	4,16 Mrd. USD
4	Sanders Capital, LLC	4,04%	3,66 Mrd. USD
5	State Street Corp	3,40%	3,08 Mrd. USD
6	FMR Inc	1,98%	1,80 Mrd. USD
7	Wellington Management Company LLP	1,76%	1,60 Mrd. USD
8	Geode Capital Management, LLC	1,66%	1,51 Mrd. USD
9	Arnhold & S. Bleichroeder Advisers, LLC	1,47%	1,33 Mrd. USD
10	Capital Research & Mgmt Co - Division 3	1,37%	1,24 Mrd. USD
11	Vanguard Portfolio Management, LLC	1,24%	1,13 Mrd. USD
12	NORGES BANK	1,22%	1,10 Mrd. USD
13	JPMorgan Chase & Co	1,11%	1,01 Mrd. USD
14	Morgan Stanley - Brokerage Accounts	1,03%	0,94 Mrd. USD
15	Arrowstreet Capital Limited Partnership	0,98%	0,88 Mrd. USD
16	The Goldman Sachs Group Inc	0,96%	0,87 Mrd. USD
17	Capital World Investors	0,89%	0,81 Mrd. USD
18	Northern Trust Corp	0,79%	0,72 Mrd. USD
19	UBS Asset Mgmt Americas Inc	0,68%	0,61 Mrd. USD
20	Nordea Investment Mgmt Bank Demark A/s	0,65%	0,59 Mrd. USD